๐Ÿ”Ž Trials Near Me

Home โ€บ Leukemia

Leukemia clinical trials recruiting in the U.S.

105 studies for Leukemia are recruiting participants at sites across the United States.

Leukemia is cancer of the white blood cells. There are two types of Leukemias, acute and chronic. Learn about the differences and treatments available.

Cities with the most studies

By state

Recently updated studies

CD70.CAR for AML and Other CD70+ Leukemias

RecruitingPhase 1
Up to age 75 ยท All sexes ยท Updated Nov 13, 2026 ยท NCT06345027

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

RecruitingPhase 3
Ages 18 and older ยท All sexes ยท Updated Nov 12, 2026 ยท NCT07007312

Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP

RecruitingPhase 2
Ages 1 to 18 ยท All sexes ยท Updated Nov 10, 2026 ยท NCT07354074

Natural History Study to Determine Drug Metabolism Phenotype and Appropriate Germline Source DNA in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplant

RecruitingObservational studyHealthy volunteers welcome
Ages 18 to 120 ยท All sexes ยท Updated Nov 9, 2026 ยท NCT06856226

Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell Therapy

RecruitingObservational studyHealthy volunteers welcome
Ages 5 and older ยท All sexes ยท Updated Nov 9, 2026 ยท NCT05237986

A Study of CHM-029 in Participants With NPM1 Mutated, KMT2A or NUP98 Rearranged AML

RecruitingPhase 1
Ages 18 and older ยท All sexes ยท Updated Nov 6, 2026 ยท NCT07751991

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

RecruitingObservational studyHealthy volunteers welcome
Ages 40 and older ยท All sexes ยท Updated Nov 4, 2026 ยท NCT05366881

A Phase II Study of the Menin Inhibitor Revumenib in Leukemia Associated With Upregulation of HOX Genes

RecruitingPhase 2
Ages 12 and older ยท All sexes ยท Updated Nov 2, 2026 ยท NCT06229912

Pivotal Open-label Phase 3 Clinical Study of QTX-2101 in Adult Patients With Acute Promyelocytic Leukemia

RecruitingPhase 3
Ages 18 to 71 ยท All sexes ยท Updated Oct 30, 2026 ยท NCT07504458

Mosaic Trial for Stem Cell Transplant Recipients

Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 30, 2026 ยท NCT06960993

Trial of 2 Step ATG for Prevention of Acute GVHD Post Allogeneic Stem Cell Transplant

RecruitingPhase 2
Ages 18 to 75 ยท All sexes ยท Updated Oct 29, 2026 ยท NCT06265584

Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution

RecruitingObservational study
Ages 0 to 38 ยท All sexes ยท Updated Oct 29, 2026 ยท NCT06131801

Natural History Study of GATA2 Deficiency and Related Disorders

RecruitingObservational studyHealthy volunteers welcome
Ages 2 to 100 ยท All sexes ยท Updated Oct 29, 2026 ยท NCT01905826

HEME Home Transfusion Program

Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 28, 2026 ยท NCT06487247

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

RecruitingObservational study
Ages 18 to 120 ยท All sexes ยท Updated Oct 28, 2026 ยท NCT01137643

Ruxolitinib Maintenance Post-Hematopoietic Stem Cell Transplant T-Cell Lymphoma

RecruitingPhase 2
Ages 18 and older ยท All sexes ยท Updated Oct 27, 2026 ยท NCT07356245

Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)

RecruitingPhase 1/2
Ages 13 to 90 ยท All sexes ยท Updated Oct 26, 2026 ยท NCT06533579

Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies

RecruitingObservational study
All ages ยท All sexes ยท Updated Oct 20, 2026 ยท NCT00736749

A Study of Revumenib and Mezigdomide in People With Leukemia

RecruitingPhase 1/2
Ages 12 and older ยท All sexes ยท Updated Oct 20, 2026 ยท NCT07356154

Leukemia and Lymphoma Society (LLS) Services Impact on Outcomes and Care

Recruiting
Ages 18 and older ยท All sexes ยท Updated Oct 16, 2026 ยท NCT05745285

AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia

RecruitingPhase 1/2
Ages 12 and older ยท All sexes ยท Updated Oct 13, 2026 ยท NCT06137118

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

RecruitingPhase 1/2
30 Days ยท All sexes ยท Updated Oct 9, 2026 ยท NCT04065399

From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.